Diagnosis and Management of Nonalcoholic Fatty Liver Disease

JAMA. 2018 Dec 18;320(23):2474-2475. doi: 10.1001/jama.2018.17365.
No abstract available

MeSH terms

  • Dyslipidemias / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Liver Cirrhosis / drug therapy
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Practice Guidelines as Topic*
  • Weight Loss

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors